Clinical Trials
3
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Home-based Transcranial Direct Current Stimulation (tDCS) for Major Depressive Disorders (MDD)
- Conditions
- Major Depressive Disorder
- First Posted Date
- 2022-01-25
- Last Posted Date
- 2022-10-05
- Lead Sponsor
- Neuroelectrics Corporation
- Target Recruit Count
- 34
- Registration Number
- NCT05205915
- Locations
- 🇺🇸
Healthcare Innovations Institute, LLC, Coral Springs, Florida, United States
🇺🇸Oceane7 Medical & Research Center, Inc., Miami, Florida, United States
🇺🇸Renew Health Clinical Research, LLC, Snellville, Georgia, United States
Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy
- Conditions
- SeizuresEpilepsy, Tonic-ClonicSeizures, FocalEpilepsyRefractory EpilepsyFocal SeizureEpilepsy in Children
- First Posted Date
- 2021-02-25
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Neuroelectrics Corporation
- Target Recruit Count
- 190
- Registration Number
- NCT04770337
- Locations
- 🇺🇸
Barrow Neurological Institute, St. Joseph's Hospital & Medical Center, Phoenix, Arizona, United States
🇺🇸Loma Linda University Health, Loma Linda, California, United States
🇺🇸Keck Medicine of USC, Los Angeles, California, United States
Safety and Therapeutic Measures of Tdcs in Patients With Refractory Focal Epilepsy
- Conditions
- Refractory Epilepsy
- First Posted Date
- 2016-08-15
- Last Posted Date
- 2021-01-11
- Lead Sponsor
- Neuroelectrics Corporation
- Target Recruit Count
- 20
- Registration Number
- NCT02866240
- Locations
- 🇺🇸
Boston Children´S Hospital, Boston, Massachusetts, United States